Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.

Koshikawa N, Mizushima H, Minegishi T, Eguchi F, Yotsumoto F, Nabeshima K, Miyamoto S, Mekada E, Seiki M.

Cancer Sci. 2011 Jan;102(1):111-6. doi: 10.1111/j.1349-7006.2010.01748.x. Epub 2010 Oct 14.

2.

Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.

Koshikawa N, Mizushima H, Minegishi T, Iwamoto R, Mekada E, Seiki M.

Cancer Res. 2010 Jul 15;70(14):6093-103. doi: 10.1158/0008-5472.CAN-10-0346. Epub 2010 Jun 29.

3.

Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.

Smith PC, Guerrero J, Tobar N, Cáceres M, González MJ, Martínez J.

J Periodontal Res. 2009 Feb;44(1):73-80. doi: 10.1111/j.1600-0765.2007.01081.x.

PMID:
19515020
4.
5.

Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain.

Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M.

J Biol Chem. 2005 Jan 7;280(1):88-93. Epub 2004 Nov 3.

6.
7.

Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site.

Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M.

J Biol Chem. 1997 Dec 12;272(50):31730-7.

8.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.

Oncol Rep. 2003 Jan-Feb;10(1):89-95.

PMID:
12469150
9.

Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.

Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R.

Gynecol Oncol. 2000 Nov;79(2):256-63.

PMID:
11063654
10.

Construction of antisense MT1-MMP vector and its inhibitory effects on invasion of human ovarian cancer cells.

Wu M, Shi Y, Xi L, Li Q, Liao GN, Han ZQ, Lu YP, Ma D.

J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):715-7.

PMID:
16696335
11.
12.
13.

Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.

Taniwaki K, Fukamachi H, Komori K, Ohtake Y, Nonaka T, Sakamoto T, Shiomi T, Okada Y, Itoh T, Itohara S, Seiki M, Yana I.

Cancer Res. 2007 May 1;67(9):4311-9.

14.
16.

Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.

Wu M, Xu G, Xi L, Wei J, Song A, Han Z, Zhou J, Wang S, Zhu T, Zhang A, Lu Y, Ma D.

Oncol Rep. 2006 Feb;15(2):501-5.

PMID:
16391876
17.

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.

Cancer Res. 2000 Feb 15;60(4):1121-8.

18.
19.

Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.

Zhang Z, Song T, Jin Y, Pan J, Zhang L, Wang L, Li P.

Int J Gynecol Cancer. 2009 Aug;19(6):998-1003. doi: 10.1111/IGC.0b013e3181a83749.

PMID:
19820359
20.

[Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].

Wu MF, Liao GN, Jia P, Xi L, Lu YP, Ma D.

Ai Zheng. 2004 Nov;23(11):1263-6. Chinese.

PMID:
15522170

Supplemental Content

Support Center